Shares of Novo Nordisk and Eli Lilly, the makers of Ozempic and Mounjaro, respectively, gained more than 50% in 2023 as demand for the drugs accelerated
Linnebjerg H, Park S, Kothare PA et al (2008) Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes
Examples of GLP-1 Weight Loss Medications Common examples include semaglutide (Wegovy, Ozempic), tirzepatide (Zepbound, Mounjaro), and Retatrutide, a new GLP-3 medication currently in clinical trials
The first method is more reliable and prevents spraying or loss of solution
only 5% of the American public gets the recommended amount, leading to a host of health issues that could be reduced or avoided with the right change of diet or supplements